Abstract:The hypothesis that dietary tomato consumption or the intake of the carotenoid lycopene inhibits prostate cancer arose from epidemiologic studies and is supported by preclinical rodent experiments and in vitro mechanistic studies. We hypothesize that variation in activity of carotenoid cleavage enzymes, such as β-carotene 9’,10’-oxygenase (BCO2), may alter the impact of dietary tomato and lycopene on prostate carcinogenesis and therefore examined this relationship in the TRAMP model. Starting at three weeks of… Show more
“…As polar extracts of the plasma were analyzed, non‐polar carotenoids were not present in these extracts. We have previously reported blood concentrations of lycopene (25 μM) in mice fed the same red tomato‐ and lycopene‐containing diets …”
Section: Resultsmentioning
confidence: 99%
“…The tomato and control diets contained placebo beadlets (0.25 %) to match the other components of the lycopene beadlets. The red tomato diet and lycopene diet were formulated to deliver the same amount of lycopene and have demonstrated biological activity in mice . Diets were stored in the dark at ‐20°C to minimize the degradation and oxidation of phytochemicals over the course of the study.…”
Section: Methodsmentioning
confidence: 99%
“…In the western diet, tomatoes and tomato products are the predominant sources of lycopene, which is absorbed and distributed to various tissues, although large interindividual variation is noted suggesting strong genetic and other factors impacting bioavailability . Studies in preclinical models of carcinogenesis have also demonstrated a protective effect of tomatoes or lycopene . Human intervention studies to prove a causal relationship between tomato or lycopene intake and reduced disease risk have not been conducted.…”
Dietary tomato glycoalkaloids are cleaved during digestion to aglycones and further metabolized post-absorption. Steroidal alkaloids in plasma may serve as novel and specific biomarkers of tomato consumption and represent a class of phytochemical metabolites that could potentially have in vivo bioactivity impacting health and disease processes.
“…As polar extracts of the plasma were analyzed, non‐polar carotenoids were not present in these extracts. We have previously reported blood concentrations of lycopene (25 μM) in mice fed the same red tomato‐ and lycopene‐containing diets …”
Section: Resultsmentioning
confidence: 99%
“…The tomato and control diets contained placebo beadlets (0.25 %) to match the other components of the lycopene beadlets. The red tomato diet and lycopene diet were formulated to deliver the same amount of lycopene and have demonstrated biological activity in mice . Diets were stored in the dark at ‐20°C to minimize the degradation and oxidation of phytochemicals over the course of the study.…”
Section: Methodsmentioning
confidence: 99%
“…In the western diet, tomatoes and tomato products are the predominant sources of lycopene, which is absorbed and distributed to various tissues, although large interindividual variation is noted suggesting strong genetic and other factors impacting bioavailability . Studies in preclinical models of carcinogenesis have also demonstrated a protective effect of tomatoes or lycopene . Human intervention studies to prove a causal relationship between tomato or lycopene intake and reduced disease risk have not been conducted.…”
Dietary tomato glycoalkaloids are cleaved during digestion to aglycones and further metabolized post-absorption. Steroidal alkaloids in plasma may serve as novel and specific biomarkers of tomato consumption and represent a class of phytochemical metabolites that could potentially have in vivo bioactivity impacting health and disease processes.
“…There is evidence from studies in transgenic mouse models of prostate cancer that metabolites similar to bixin are the molecular species responsible for the cancer preventive effects of lycopene. 138 Bixin has an excellent safety record and good systemic bioavailability when orally administered. A team from the Arizona Cancer Center recently reported that intraperitoneal injection of bixin activates the transcription factor Nrf2 and thereby induces an antioxidant response in a mouse model of UVinduced photodamage and inflammation.…”
Section: Lycopene and Related Carotenoidsmentioning
confidence: 99%
“…It is used worldwide as a dietary additive and cosmetic ingredient known as annatto. There is evidence from studies in transgenic mouse models of prostate cancer that metabolites similar to bixin are the molecular species responsible for the cancer preventive effects of lycopene 137 . Bixin has an excellent safety record and good systemic bioavailability when administered orally.…”
Recent progress in the treatment of advanced melanoma has led to unprecedented improvements in overall survival. As these new melanoma treatments have been developed and deployed in the clinic, much has been learned about the natural history of the disease. Now is the time to apply that knowledge towards the design and clinical evaluation of new chemoprevention agents. Melanoma chemoprevention has the potential to dramatically reduce both the morbidity and high costs associated with treating patients with metastatic disease. In this work, scientific and clinical melanoma experts from the national Melanoma Prevention Working Group comprised of National Cancer Trials Network (NCTN) participants, discuss research aimed at discovering and developing (or re-purposing) drugs and natural products for the prevention of melanoma, and propose an updated pipeline for translating the most promising agents into the clinic. The mechanism of action, pre-clinical data, epidemiological evidence and results of available clinical trials are discussed for each class of compounds. Selected keratinocyte carcinoma chemoprevention studies are also considered, and a rationale for their inclusion is presented. These data are summarized in a table that lists the type and level of evidence available for each class of agents. Also included in the discussion is an assessment of additional research necessary and likelihood that a given compound might be a suitable candidate for a Phase III clinical trial within the next 5 years.
Scope: -Cryptoxanthin (BCX) can be cleaved by both -carotene 15,15′-oxygenase (BCO1) and -carotene 9′,10′-oxygenase (BCO2), generating biological active vitamin A and apocarotenoids. We examined whether BCX feeding could inhibit diethylnitrosamine (DEN)-initiated, highly refined carbohydrate diet (HRCD)-promoted hepatocellular carcinoma (HCC) development, dependent or independent of BCO1/BCO2 activity. Methods and results: Two-week-old male wild-type (WT) and BCO1 −/− /BCO2 −/− double knockout (DKO) mice are given a single intraperitoneal injection of DEN (25 mg kg −1 body weight) to initiate hepatic carcinogenesis. At 6 weeks of age, all animals are fed HRCD (66.5% of energy from carbohydrate) with or without BCX for 24 weeks. BCX feeding increases hepatic vitamin A levels in WT mice, but not in DKO mice that shows a significant accumulation of hepatic BCX. Compared to their respective HRCD littermates, both WT and DKO fed BCX have significantly lower HCC multiplicity, average tumor size, and total tumor volume, and the steatosis scores. The chemopreventive effects of BCX are associated with increased p53 protein acetylation and decreased protein levels of lactate dehydrogenase and hypoxia-inducible factor-1 in tumors. Conclusion: This study suggests that BCX feeding may alleviate HRCD-promoted HCC progression by modulating the acetylation of p53, hypoxic tumor microenvironment, and glucose metabolism, independent of BCO1/BCO2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.